Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TapImmune granted immune response related patent
TAP molecules are proteins responsible for supplying tumor-associated antigens (markers) and viral antigens to the surface of infected cells. Without TAP, there are no cancer markers, so the
TAP molecules are proteins responsible for supplying tumor-associated antigens (markers) and viral antigens to the surface of infected cells. Without TAP, there are no cancer markers, so the
Ron Najafi, chairman and CEO of NovaBay, said: “We are very pleased to have received rapid clearance of this important investigational new drug application (IND), as this enables
The purchase price to be paid to Hologic as a result of the transaction is $82 million in cash, $7.5 million of which is payable at the closing
The commission has initiated a two-part study of pharmaceutical distribution channels in December 2006. The first part of the study, dealing with safe medicines in parallel trade, was
The company will use the proceeds from the financing for continued development of ClearPath, the company’s breast brachytherapy device, as well as working capital. Three Arch Partners led
Under the terms of the agreement, Forest will pay Novexel an upfront license payment of E75 million. Forest will fund development and commercialization of the ceftaroline/NXL 104 combination.
The collaboration will utilize Aureon’s integrated systems pathology approach, whereby data generated from tissue morphometry, multiplexed-protein biomarkers, and in situ RNA expression are integrated with patient clinical information
ImaRx intends to transfer the manufacturing process and NDA to Microbix creating a new source for urokinase. This new supply of urokinase will allow ImaRx to continue to
Rubicon plans to use its MethylPlex platform to carry out the marker identification analysis. As part of the agreement, Rubicon granted an option to OncoMethylome for licensing markers
The Towne strain is an attenuated, or weakened, form of human cytomegalovirus (CMV) developed for potential vaccine applications. Vijay Samant, president and CEO of Vical, said: “CMV is